4.7 Article

The study of angiogenesis stimulated by multivalent peptide ligand-modified alginate

期刊

COLLOIDS AND SURFACES B-BIOINTERFACES
卷 154, 期 -, 页码 383-390

出版社

ELSEVIER SCIENCE BV
DOI: 10.1016/j.colsurfb.2017.03.049

关键词

Angiogenesis; Multivalent ligand; REDV sequence; Gold nanoparticle; Endothelial cell selectivity

资金

  1. National Natural Science Foundation of China [51273095, 51433004]
  2. Natural Science Foundation of Tianjin [14JCQNJC03500]
  3. NFFTBS [J1103306]
  4. PCSIRT [IRT1257]

向作者/读者索取更多资源

Enhancing the affinity of scaffolds for endothelial cell (EC) is a crucial procedure for promoting angiogenesis in tissue engineering. In this work, to achieve stronger binding affinity with ECs, the peptide sequence REDV was conjugated onto gold nanoparticles (AuNPs) to construct a multivalent ligand (cREDV). Then, the EC adhesion and proliferation were studied to determine ligand affinity for ECs in vitro. The results show that the cREDV-modified alginate (cREDV-ALG) surface exhibited a selective adhesion to human umbilical vein endothelial cells (HUVECs) compared with NIH 3T3 cells. The average area of individual HUVEC that adhered to cREDV-ALG was approximately 2.27-fold higher than that adhered to the monovalent REDV-modified alginate (REDV-ALG) surface. Additionally, a superior ability to promote the proliferation of HUVECs compared to the REDV-ALG surface was demonstrated. In vivo angiogenic assays were also carried out to assess the effect of multivalent strategy on the vascularization of scaffolds. The results illustrated that cREDV-ALG could stimulate new vessel formation in the scaffold, and the blood vessel density was at least 20% higher than that observed with monovalent REDV-ALG with a similar degree of ligand substitution. These results demonstrated that a multivalent ligand strategy was beneficial for the vascularization of engineered tissues. (C) 2017 Elsevier B.V. All rights reserved.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据